Does Dr. THOMAS ABRAMS have financial conflicts of interest?

Dr. THOMAS ABRAMS (M.D.) has received a total of $78,849 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $69,205 in personal promotional payouts (consulting, meals, travel) and $9,644 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. THOMAS ABRAMS?

According to CMS Open Payments data, Dr. THOMAS ABRAMS received funding from ASTRAZENECA PHARMACEUTICALS ($23,903), E.R. SQUIBB & SONS, L.L.C ($20,625), and EISAI ($10,654).

Does Dr. THOMAS ABRAMS receive research grants or speaking fees?

Dr. THOMAS ABRAMS has received $69,205 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $9,644 in clinical research grants.

DR. THOMAS ABRAMS

M.D.Real-Time Hydrated

Specialty: Internal Medicine, Medical Oncology

Practice Location: BOSTON, MA 02115

NPI Number: 1184693947

LIFETIME INDUSTRY VALUE

$78,849

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABRAMS is a verified Internal Medicine, Medical Oncology practitioner based in BOSTON, MA.

Between 2021 and 2024, Dr. ABRAMS had an overall industry promotional and research financial footprint of $78,849 as recorded in the federal CMS Open Payments database.

$69,205 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$9,644 was allocated to sponsored clinical trials and medical research activities.

Dr. ABRAMS's primary funding source is ASTRAZENECA PHARMACEUTICALS, which accounts for $23,903 (representing 30.3% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ASTRAZENECA PHARMACEUTICALS

Rank 1

$23,903

30.3%

E.R. SQUIBB & SONS, L.L.C

Rank 2

$20,625

26.2%

EISAI

Rank 3

$10,654

13.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.